Ubs Asset Management Americas Inc Ligand Pharmaceuticals Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 39,838 shares of LGND stock, worth $4.75 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,838
Previous 45,869
13.15%
Holding current value
$4.75 Million
Previous $3.86 Million
3.26%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding LGND
# of Institutions
257Shares Held
18.2MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$342 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$235 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$120 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$106 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$84.3 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.01B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...